Literature DB >> 3722420

Technique for measuring 50% end points in cytotoxicity assays for Clostridium difficile toxins.

S W Rothman.   

Abstract

Serial dilutions of Clostridium difficile culture filtrates were incubated overnight with HeLa cell monolayers. Cells were fixed in formalin, stained with crystal violet, rinsed, and drained. Cell rounding could be observed microscopically in the stained monolayers. Absorbance of the retained dye on monolayers in the drained wells was measured at 595 nm-405 nm. End points could also be estimated visually. The dilution at which dye absorbance was reduced by 50% agreed with that determined by microscopic observations. Five replicate dilution series showed high reproducibility. Specificity was verified by neutralisation with crude rabbit antibody to C difficile toxins. Cytotoxicity in faecal specimens was assayed in the same way, allowing reporting of titres, comparison with standard toxin preparations, and determination of the extent of neutralisation to be made. This novel assay technique has proved effective and reliable in a clinical setting and should allow the gathering of more information on the epidemiology of antibiotic associated colitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722420      PMCID: PMC499990          DOI: 10.1136/jcp.39.6.672

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Cytotoxicity assay in antibiotic-associated colitis.

Authors:  T W Chang; M Lauermann; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

2.  Inhibition of protein synthesis in intact HeLa cells by Shigella dysenteriae 1 toxin.

Authors:  J E Brown; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

3.  The non-value of counterimmunoelectrophoresis for the direct rapid detection of Clostridium difficile toxin in stool filtrates.

Authors:  M Sands; M Yungbluth; H M Sommers
Journal:  Am J Clin Pathol       Date:  1983-03       Impact factor: 2.493

4.  A micro-method for detecting toxins in pseudomembranous colitis.

Authors:  R H George
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

5.  Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.

Authors:  J E Brown; D E Griffin; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin.

Authors:  S E West; T D Wilkins
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

7.  Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.

Authors:  S W Rothman; J E Brown; A Diecidue; D A Foret
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

9.  Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis.

Authors:  D F Welch; S K Menge; J M Matsen
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

10.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

View more
  4 in total

1.  PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital.

Authors:  G Martirosian; S Kuipers; H Verbrugh; A van Belkum; F Meisel-Mikolajczyk
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

2.  Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms.

Authors:  Xiang-He Lei; Barry R Bochner
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

3.  Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.

Authors:  Ken Watanabe; Takeshi Ishikawa; Hiroki Otaki; Satoshi Mizuta; Tsuyoshi Hamada; Takehiro Nakagaki; Daisuke Ishibashi; Shuzo Urata; Jiro Yasuda; Yoshimasa Tanaka; Noriyuki Nishida
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

4.  Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.

Authors:  Michael Maynard-Smith; Helen Ahern; Joanna McGlashan; Philip Nugent; Roger Ling; Harriet Denton; Ruth Coxon; John Landon; April Roberts; Clifford Shone
Journal:  Vaccine       Date:  2013-12-14       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.